Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.215    0.00 (0.00%)
Bid:
0.18
Ask:
0.25
Spread: 0.07 (38.889%)
Market Cap: £1.13m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

EPT Disclosure

20 May 2008 11:25

RNS Number : 8634U
UBS AG (EPT)
20 May 2008
 

FORM 38.5(b)

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

 

 

1. KEY INFORMATION

 

Name of exempt principal trader

UBS AG London Branch

Company dealt in

Expro International Group Plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

10p Ordinary

Date of dealing

19 MAY 2008

 

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a) Interests and short positions (following dealing) in the class of 

relevant security dealt in (Note 2)

 

 

Long

 

Short

 

 

Number

(%)

Number 

(%)

(1) Relevant securities 

472,563

0.43%

0

0.00%

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

472,563

0.43%

0

0.00%

(b) Interests and short positions in relevant securities of

the company, other than the class dealt in (Note 2)

 

Class of relevant security:

Long

 

Short

 

 

Number 

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

Rights to subscribe (Note 2)

Class of relevant security:

Details

3. DEALINGS (Note 3)

 (a) Purchases and sales

Purchase/sale

Number of securities

Price per unit (Note 4)

PURCHASE

295

1525 pence

PURCHASE

3

1526

PURCHASE

272

1526

PURCHASE

321

1526

PURCHASE

327

1526

PURCHASE

500

1526

PURCHASE

1034

1526

SALE

20

1527

PURCHASE

298

1527

SALE

20

1529

PURCHASE

60

1529

PURCHASE

135

1529

PURCHASE

136

1529

PURCHASE

148

1529

PURCHASE

311

1529

PURCHASE

320

1532

PURCHASE

676

1532

SALE

645

1534

SALE

295

1534

SALE

100

1534

SALE

2634

1535

SALE

23

1535

PURCHASE

78

1535

PURCHASE

225

1535

PURCHASE

225

1535

PURCHASE

1265

1535

SALE

722

1536

SALE

100

1536

PURCHASE

252

1536

SALE

23

1537

SALE

14

1537

PURCHASE

526

1537

SALE

348

1538

SALE

300

1538

SALE

252

1538

SALE

248

1538

SALE

900

1539

SALE

229

1539

SALE

66

1539

PURCHASE

99

1539

PURCHASE

269

1539

PURCHASE

585

1539

PURCHASE

1500

1539

TOTAL PURCHASES

9,860

TOTAL SALES

6,939

(b) Derivatives transactions (other than options)

Product name, e.g CFD

Long/short (Note 5)

Number of securities (Note 6)

Price per unit (Note 4)

 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling, purchasing, varying etc

Number of securities to which the option relates (Note 6)

Exercise price 

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 4)

 

(d) Other dealings (including new securities) (Note 3)

 

Nature of transaction(Note 7)

Details

Price per unit (if applicable)

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

……………………………………………………………………

 

……………………………………………………………………

 

Is a Supplemental Form 38.5(b) attached? (Note 8) NO

 

Date of disclosure

20 MAY 2008

Contact name

LOUISE ROBINSON

Telephone number

020 7567 8762

Name of offeree/offeror with which connected

Halliburton Company

Nature of connection (Note 9)

CONNECTED ADVISER

Notes

The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMBGGDUUDDGGIG
Date   Source Headline
3rd Mar 202312:00 pmRNSResult of EGM
27th Feb 20233:45 pmRNSSigning of Subscription Agreement and TVR
7th Feb 202311:45 amRNSPosting of Circular
6th Feb 202312:00 pmRNS£8.8 million Placing
6th Feb 20237:00 amRNSProposed Placing of New Ordinary Shares
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSENGAGE showcases first AI-powered virtual employee
18th Jan 20237:00 amRNSFY2022 Trading Update and Notice of Results
12th Dec 20222:05 pmRNSSecond Price Monitoring Extn
12th Dec 20222:00 pmRNSPrice Monitoring Extension
12th Dec 202211:05 amRNSSecond Price Monitoring Extn
12th Dec 202211:00 amRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSTrading Update
21st Nov 20227:00 amRNSCommercial reseller agreement signed with Lenovo
7th Nov 20227:00 amRNSLaunch of ENGAGE Link & Investor Presentation
28th Sep 202211:00 amRNSENGAGE XR to collaborate with Lenovo
21st Sep 20222:09 pmRNSHolding(s) in Company
13th Sep 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSInvestor Presentation
2nd Aug 20227:00 amRNSPre-Close Trading Update and Notice of Results
18th Jul 202211:00 amRNSDirectors’ Disclosure
23rd Jun 20227:00 amRNSENGAGE & METAVERSE UPDATE
16th Jun 202211:58 amRNSResult of AGM
16th May 20224:11 pmRNSNotice of AGM, Posting of Annual Report & Accounts
7th Apr 20224:40 pmRNSSecond Price Monitoring Extn
7th Apr 20224:35 pmRNSPrice Monitoring Extension
7th Apr 20227:00 amRNSEngage and Victory XR to Launch 10 Metaversities
28th Mar 20227:00 amRNSNew Senior Appointments to help drive US Growth
8th Mar 20227:01 amRNSFinal Results
4th Mar 202211:30 amRNSAIM Rule 17 Schedule 2(g) Update
16th Feb 20227:00 amRNSNotice of Results & Investor Presentation
31st Jan 20227:00 amRNSPre-Close Trading Update & Directorate Change
23rd Nov 20217:00 amRNSDirectorate Changes
12th Nov 20217:00 amRNSENGAGE Update & Investor Presentation
5th Nov 202110:24 amRNSExercise of Options
1st Jul 20081:02 pmRNSDirector Dealings
1st Jul 200811:16 amRNSScheme Effective
30th Jun 20085:52 pmRNSHolding(s) in Company
30th Jun 20083:03 pmRNSRule 8.3- Expro International
30th Jun 20082:19 pmBUSRule 8.3 - Expro International
30th Jun 200812:52 pmRNSEPT Disclosure - Expro Intern
30th Jun 200812:42 pmRNSEPT Disclosure - Expro Intl G
30th Jun 200812:37 pmRNSEPT Disclosure - Expro Intern
30th Jun 200812:11 pmRNSRule 8.3- Expro International
30th Jun 200811:16 amRNSHolding(s) in Company
30th Jun 200811:03 amRNSScheme of arrangement
27th Jun 20085:01 pmRNSRule 2.10 Announcement
27th Jun 20085:00 pmRNSSuspension - Expro Internatio
27th Jun 20084:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.